128 related articles for article (PubMed ID: 2278639)
1. Myelofibrosis: a review of clinical and pathologic features and treatment.
Smith RE; Chelmowski MK; Szabo EJ
Crit Rev Oncol Hematol; 1990; 10(4):305-14. PubMed ID: 2278639
[TBL] [Abstract][Full Text] [Related]
2. Myelofibrosis: a concise review of clinical and pathologic features and treatment.
Smith RE; Chelmowski MK; Szabo EJ
Am J Hematol; 1988 Nov; 29(3):174-80. PubMed ID: 3055953
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Myelofibrosis: A Moving Target.
Cerquozzi S; Farhadfar N; Tefferi A
Cancer J; 2016; 22(1):51-61. PubMed ID: 26841017
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of idiopathic myelofibrosis.
Reilly JT
Baillieres Clin Haematol; 1998 Dec; 11(4):751-67. PubMed ID: 10640215
[TBL] [Abstract][Full Text] [Related]
6. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
[TBL] [Abstract][Full Text] [Related]
7. [Reversal of myelofibrosis is an important pre-transplant factor for bone marrow grafting--a successful case of allogeneic bone marrow transplantation for an acute megakaryoblastic leukemia].
Masauzi N; Tanaka J; Ohizumi H; Kiyama Y; Naohara T; Higa T; Kasai M; Imamura M; Miyazaki T
Rinsho Ketsueki; 1994 Feb; 35(2):148-53. PubMed ID: 8139112
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory features of myelofibrosis and limitations of current therapies.
Gregory SA; Mesa RA; Hoffman R; Shammo JM
Clin Adv Hematol Oncol; 2011 Sep; 9(9 Suppl 22):1-16. PubMed ID: 22362131
[TBL] [Abstract][Full Text] [Related]
10. Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis.
Schmitt A; Drouin A; Massé JM; Guichard J; Shagraoui H; Cramer EM
Leuk Lymphoma; 2002 Apr; 43(4):719-24. PubMed ID: 12153156
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic myelofibrosis: pathogenesis, natural history and management.
Reilly JT
Blood Rev; 1997 Dec; 11(4):233-42. PubMed ID: 9481452
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic myelofibrosis: a clinical review.
Manoharan A
Int J Hematol; 1998 Dec; 68(4):355-62. PubMed ID: 9885435
[TBL] [Abstract][Full Text] [Related]
14. A variant form of acute promyelocytic leukemia with marked myelofibrosis.
Fukuno K; Tsurumi H; Yoshikawa T; Yamada T; Oyama M; Moriwaki H
Int J Hematol; 2001 Oct; 74(3):322-6. PubMed ID: 11721970
[TBL] [Abstract][Full Text] [Related]
15. Megakaryocyte colony formation in chronic myeloid leukemia and myelofibrosis.
Juvonen E
Leuk Res; 1988; 12(9):751-6. PubMed ID: 3193813
[TBL] [Abstract][Full Text] [Related]
16. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
[TBL] [Abstract][Full Text] [Related]
17. A review of myelofibrosis in dogs.
Reagan WJ
Toxicol Pathol; 1993; 21(2):164-9. PubMed ID: 8210938
[TBL] [Abstract][Full Text] [Related]
18. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
Pizzi M; Gergis U; Chaviano F; Orazi A
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis: a possible role for interferon in the treatment of idiopathic myelofibrosis.
Hasselbalch H
Med Hypotheses; 1988 Dec; 27(4):345-7. PubMed ID: 3226365
[TBL] [Abstract][Full Text] [Related]
20. New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment.
Palandri F; Auteri G; Baccarani M
Hematol Oncol; 2017 Jun; 35(2):145-150. PubMed ID: 27510853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
